CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response.

Nat Commun · 2018 · PMC6189038 · PMID 30323222

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

We observed a strong trend in the consistency between the DREBIC score-based ranking and the actual experimental data, suggesting that DREBIC captures the inherent biological response of various cancer cell lines (Fig. 4e ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.